Created at Source Raw Value Validated value
Nov. 26, 2021, 10:30 p.m. oms

1.Patients with autoimmune disease or self-reports HIV or syphilis infection <br/ >2.Subject suffering from disorders where Aspirin is contraindicated and/or as per the discretion of investigator <br/ >3.Proves to be unfit for the study as per the investigatorâ??s discretion <br/ >4.Pregnant or lactating women <br/ >5.Requiring hospital admission at screening <br/ >6.Any other comorbidity which is critical stage at screening which in investigator discretion finds subject not suitable for the trial participation <br/ >

1.Patients with autoimmune disease or self-reports HIV or syphilis infection <br/ >2.Subject suffering from disorders where Aspirin is contraindicated and/or as per the discretion of investigator <br/ >3.Proves to be unfit for the study as per the investigatorâ??s discretion <br/ >4.Pregnant or lactating women <br/ >5.Requiring hospital admission at screening <br/ >6.Any other comorbidity which is critical stage at screening which in investigator discretion finds subject not suitable for the trial participation <br/ >

Nov. 13, 2021, 5:33 p.m. oms

N/A

N/A

Sept. 8, 2021, 1:30 a.m. oms

1.Patients with autoimmune disease or self-reports HIV or syphilis infection <br/ >2.Subject suffering from disorders where Aspirin is contraindicated and/or as per the discretion of investigator <br/ >3.Proves to be unfit for the study as per the investigatorâ??s discretion <br/ >4.Pregnant or lactating women <br/ >5.Requiring hospital admission at screening <br/ >6.Any other comorbidity which is critical stage at screening which in investigator discretion finds subject not suitable for the trial participation <br/ >

1.Patients with autoimmune disease or self-reports HIV or syphilis infection <br/ >2.Subject suffering from disorders where Aspirin is contraindicated and/or as per the discretion of investigator <br/ >3.Proves to be unfit for the study as per the investigatorâ??s discretion <br/ >4.Pregnant or lactating women <br/ >5.Requiring hospital admission at screening <br/ >6.Any other comorbidity which is critical stage at screening which in investigator discretion finds subject not suitable for the trial participation <br/ >